[HTML][HTML] CD8+ T cells in HIV control, cure and prevention

DR Collins, GD Gaiha, BD Walker - Nature Reviews Immunology, 2020 - nature.com
HIV infection can be effectively treated by lifelong administration of combination antiretroviral
therapy, but an effective vaccine will likely be required to end the HIV epidemic. Although the …

Human circulating and tissue-resident memory CD8+ T cells

M Buggert, DA Price, LK Mackay, MR Betts - Nature Immunology, 2023 - nature.com
Our current knowledge of human memory CD8+ T cells is derived largely from studies of the
intravascular space. However, emerging data are starting to challenge some of the dogmas …

[HTML][HTML] Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones

JA Collora, R Liu, D Pinto-Santini, N Ravindra… - Immunity, 2022 - cell.com
Understanding the drivers and markers of clonally expanding HIV-1-infected CD4+ T cells is
essential for HIV-1 eradication. We used single-cell ECCITE-seq, which captures surface …

Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans

KB Yates, P Tonnerre, GE Martin, U Gerdemann… - Nature …, 2021 - nature.com
T cell exhaustion is an induced state of dysfunction that arises in response to chronic
infection and cancer. Exhausted CD8+ T cells acquire a distinct epigenetic state, but it is not …

Cytolytic CD8+ T cells infiltrate germinal centers to limit ongoing HIV replication in spontaneous controller lymph nodes

DR Collins, J Hitschfel, JM Urbach… - Science …, 2023 - science.org
Follicular CD8+ T cells (fCD8) mediate surveillance in lymph node (LN) germinal centers
against lymphotropic infections and cancers, but the precise mechanisms by which these …

[HTML][HTML] The identity of human tissue-emigrant CD8+ T cells

M Buggert, LA Vella, S Nguyen, VH Wu, Z Chen… - Cell, 2020 - cell.com
Lymphocyte migration is essential for adaptive immune surveillance. However, our current
understanding of this process is rudimentary, because most human studies have been …

The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy

D SenGupta, C Brinson, E DeJesus, A Mills… - Science translational …, 2021 - science.org
Toll-like receptor 7 (TLR7) agonists, in combination with other therapies, can induce
sustained control of simian-human immunodeficiency virus (SHIV) or simian …

[HTML][HTML] Insights into persistent HIV-1 infection and functional cure: novel capabilities and strategies

TM Ta, S Malik, EM Anderson, AD Jones… - Frontiers in …, 2022 - frontiersin.org
Although HIV-1 replication can be efficiently suppressed to undetectable levels in peripheral
blood by combination antiretroviral therapy (cART), lifelong medication is still required in …

[HTML][HTML] Immunological approaches to HIV cure

AR Ward, TM Mota, RB Jones - Seminars in immunology, 2021 - Elsevier
Combination antiretroviral therapy (ART) to treat human immunodeficiency virus (HIV)
infection has proven remarkably successful–for those who can access and afford it–yet HIV …

[HTML][HTML] TCF-1 regulates HIV-specific CD8+ T cell expansion capacity

RL Rutishauser, CDT Deguit, J Hiatt, F Blaeschke… - JCI insight, 2021 - ncbi.nlm.nih.gov
Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the
virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory …